STAT

Ebola outbreak in DRC sets up another test for experimental treatments

A handful of experimental therapeutics may be available to try to quell the world's latest Ebola outbreak.
An aid worker from the Democratic Republic of Congo gets vaccinated against Ebola in Mbandaka in May.

In the world of Ebola outbreaks, lucky breaks are few and far between. But it appears the Democratic Republic of the Congo may have caught a small one in its latest go-round with the dangerous disease.

And it might also give the world another shot at testing an experimental Ebola vaccine.

Officials in the DRC said Thursday that testing has shown that the province in the northeast of the

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks